PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
02-May-2023 Amolyt Pharma Announces Phase 3 Clinical Trial of Eneboparatide for the Treatment of Hypoparathyroidism following Positive End of Phase 2 Meeting with FDA Amolyt Pharma
02-May-2023 OKYO Pharma Announces First-Patient First-Visit for Phase 2 Trial Evaluating Efficacy and Safety of OK-101 in Patients with Dry Eye Disease OKYO Pharma
02-May-2023 Destiny Pharma and SporeGen® announce update from research collaboration under Innovate UK grant award to develop a biotherapeutic treatment (SPOR-COV®) for COVID-19 and Influenza Destiny Pharma
02-May-2023 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
02-May-2023 Biophytis strengthens its management team Biophytis
02-May-2023 Defence Therapeutics Inc.: DEFENCE’S SUCCESFULL ACCUTOXTM PRE-CLINICAL EFFICACY STUDY COMPLETE READY FOR PHASE I IND FILING Defence Therapeutics Inc.
02-May-2023 Newron announces Senior Management Team changes Newron Pharmaceuticals S.p.A.
02-May-2023 SKAN increases stake in Aseptic Technologies to 85 percent SKAN AG
01-May-2023 IGEA Pharma N.V.: IGEA to get SIX approval to Annual Report 2022 disclosure IGEA Pharma N.V.
01-May-2023 Mainz Biomed to Participate in Digestive Disease Week 2023 Mainz BioMed N.V.
01-May-2023 Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA™ Commercial Launch Progressing Ahead of Schedule Relief Therapeutics Holding SA
30-Apr-2023 Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects Vita 34 AG
28-Apr-2023 Biophytis announces receipt of Nasdaq Notice Biophytis
28-Apr-2023 Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders Relief Therapeutics Holding SA
28-Apr-2023 atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late Breaking Poster Presentation at the 2023 SOBP Annual Meeting atai Life Sciences
28-Apr-2023 ImmunoGen Reports Recent Progress and First Quarter 2023 Financial Results ImmunoGen
28-Apr-2023 Consolidation in FY/2022: Small decline in sales with stable cost base and strong improvement in operating cash flow (+23 %) in challenging environment aap Implantate AG
28-Apr-2023 CHEPLAPHARM places notes in a volume of €750m in challenging market environment Cheplapharm AG
28-Apr-2023 Asklepios Kliniken: Solid performance in 2022 Asklepios Kliniken
28-Apr-2023 Biotest AG: Biotest and Grifols further strengthen their cooperation - EBIT forecast 2023 significantly raised Biotest AG